Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 11/20 | 0.60 |
| ▸ | TSHR | P16473 | 4/20 | 0.60 |
| ▸ | TP53 | P04637 | 1/20 | 0.60 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.60 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.40 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.35 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.35 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL27560148 | 1.00 | HCAR2 (0.60) | HCAR2TSHRTP53EGLN1EGLN3 | |
| SCHEMBL1238140 | 1.00 | HCAR2 (0.60) | HCAR2TSHRTP53EGLN1EGLN3 | |
| SCHEMBL499484 | 1.00 | HCAR2 (0.60) | HCAR2TSHRTP53EGLN1EGLN3 | |
| SCHEMBL63810 | 1.00 | HCAR2 (0.60) | HCAR2TSHRTP53EGLN1EGLN3 | |
| Maleic Acid SCHEMBL5822456 | 1.00 | HCAR2 (0.60) | HCAR2TSHRTP53EGLN1EGLN3 | |
| SCHEMBL4949804 | 1.00 | HCAR2 (0.60) | HCAR2TSHRTP53EGLN1EGLN3 | |
| Maleic Acid SCHEMBL8418674 | 1.00 | HCAR2 (0.60) | HCAR2TSHRTP53EGLN1EGLN3 | |
| SCHEMBL2402992 | 1.00 | HCAR2 (0.60) | HCAR2TSHRTP53EGLN1EGLN3 | |
| Maleic Acid SCHEMBL20487518 | 1.00 | HCAR2 (0.60) | HCAR2TSHRTP53EGLN1EGLN3 | |
| Fumaric Acid SCHEMBL27731205 | 1.00 | HCAR2 (0.60) | HCAR2TSHRTP53EGLN1EGLN3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230011640-A1 | METHODS FOR RECOVERING ORGANIC SALTS FROM INDUSTRIAL PROCESS STREAMS | CYTEC INDUSTRIES INC. (US) | 2023-01-12 | — | — | US | disclosed |
| EP-4073000-A1 | METHODS FOR RECOVERING ORGANIC SALTS FROM INDUSTRIAL PROCESS STREAMS | Cytec Industries, Inc. (US) | 2022-10-19 | — | — | EP | disclosed |
| WO-2021118938-A1 | METHODS FOR RECOVERING ORGANIC SALTS FROM INDUSTRIAL PROCESS STREAMS | CYTEC INDUSTRIES INC. (US) | 2021-06-17 | — | — | WO | disclosed |
| CN-111465394-A | Drugs and compositions for ocular delivery | 灰色视觉公司 | 2020-07-28 | — | — | CN | disclosed |
| US-8435411-B2 | Methods and compositions for the removal of impurities from an impurity-loaded organic salt | CYTEC TECHNOLOGY CORP. (US) | 2013-05-07 | — | — | US | disclosed |
| EP-2512614-A1 | METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES FROM AN IMPURITY-LOADED IONIC LIQUID | Cytec Technology Corp. (US) | 2012-10-24 | — | — | EP | disclosed |
| WO-2011081764-A1 | METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES FROM AN IMPURITY-LOADED IONIC LIQUID | CYTEC TECHNOLOGY CORP. (US) | 2011-07-07 | — | — | WO | disclosed |
| US-20110140037-A1 | METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES FROM AN IMPURITY-LOADED ORGANIC SALT | CYTEC TECHNOLOGY CORP. (US) | 2011-06-16 | — | — | US | disclosed |
| CN-101534808-A | Modified release formulations of bupropion salts | BIOVAIL LAB INT SRL (BB) | 2009-09-16 | — | — | CN | disclosed |
| CN-1033026-C | Improved temperature control process for the preparation of 2, 2' -oxodisuccinates as laundry detergent builders | PROCTER & GAMBLE (US) | 1996-10-16 | — | — | CN | disclosed |
| CN-1117042-A | Improved, controlled temperature process for making2,2'-oxodisuccinates useful as laundry detergent builders | PROCTER & GAMBLE (US) | 1996-02-21 | — | — | CN | disclosed |
| US-5298634-A | Reacting maleate or mixture with 2,2-oxodisuccinate, fumarate and malate, calcium, magnesium divalent cations and rendering reaction mixture alkaline by adding hydroxide | THE PROCTER & GAMBLE COMPANY (US) | 1994-03-29 | — | — | US | disclosed |
| US-4910267-A | Sulfur vulcanized copolymer of an unsaturated nitrile, conjugated diene and an unsaturated carboxylic group | NIPPON ZEON CO., LTD. (JP) | 1990-03-20 | — | — | US | disclosed |
| US-4847262-A | CENTRAL NERVOUS SYSTEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-07-11 | — | — | US | disclosed |
| CN-85104237-A | The preparation method of 3-amino-pyrazol base (3,4-d) pyrimidine derivatives | — | 1986-12-03 | — | — | CN | disclosed |
| US-4379790-A | (Erolinyl)-N,N-diethylurea derivatives, and their preparation and use | SCHERING AKTIENGESELLSCHAFT (DE) | 1983-04-12 | — | — | US | disclosed |
| US-4318911-A | 5,6-Diaryl-1,2,4-triazines as topical antithrombotic agents | ELI LILLY AND COMPANY (US) | 1982-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110140037-A1 | METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES FROM AN IMPURITY-LOADED ORGANIC SALT | OSTC, SLC10A6, SLC22A8 | HCAR2 4581/4885TSHR 4622/4885TP53 1533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.